Can I Take Saw Palmetto With Metformin for PCOS?

What You Actually Need to Know First

Saw palmetto is one of the most commonly purchased supplements for PCOS-related androgen excess, used by women trying to address hirsutism, hormonal acne, and female pattern hair loss without a prescription drug. Metformin ER is the standard first-line medication for insulin resistance in PCOS, recommended by ACOG Practice Bulletin 194 and the ASRM PCOS guidelines.

Women combine them more often than their doctors realize. A 2016 survey published in the Journal of Clinical Endocrinology and Metabolism found that roughly 40% of women with PCOS were using at least one herbal or dietary supplement alongside their prescribed medications, and fewer than half had disclosed this to their clinician.

That matters because the absence of a pharmacokinetic interaction does not mean the combination is automatically risk-free.

What Metformin ER Does in PCOS

Metformin ER (extended-release metformin) reduces hepatic glucose output, improves peripheral insulin sensitivity, and lowers circulating insulin levels. In PCOS, chronically elevated insulin drives the ovarian theca cells to overproduce androgens. By lowering insulin, metformin ER indirectly reduces free testosterone and DHEA-S in many women. A 2014 Cochrane review confirmed that metformin improves ovulation rates compared to placebo in women with PCOS, though it is less effective than letrozole for live birth when ovulation induction is the primary goal.

Standard dosing in PCOS is typically 1,500 to 2,000 mg per day taken with the evening meal to reduce GI side effects. The extended-release formulation is preferred for tolerability.

What Saw Palmetto Does (and How It Relates to PCOS)

Saw palmetto (Serenoa repens) is extracted from the berry of a North American palm. Its main proposed mechanism is inhibition of 5-alpha-reductase (5-AR), the enzyme that converts testosterone into its more potent form, dihydrotestosterone (DHT). A 2012 study in the Journal of Alternative and Complementary Medicine found that saw palmetto extract inhibits both type 1 and type 2 isoforms of 5-AR in vitro, which is relevant because type 1 is expressed in the skin and sebaceous glands where DHT drives hirsutism and acne.

In PCOS, this sounds appealing. Elevated androgens are the clinical signature of the condition, and DHT is the primary driver of terminal hair growth on the face and body, as well as androgenic alopecia. Saw palmetto offers an over-the-counter alternative to spironolactone or finasteride for women who want to reduce androgen activity at the tissue level.

The evidence is thin. Most saw palmetto trials enrolled men with benign prostatic hyperplasia, not women with PCOS. The STEP study, which is the largest high-quality trial of saw palmetto, enrolled only men. Female-specific trial data on saw palmetto for androgenic conditions is largely absent from the literature, and this is a genuine evidence gap you should weigh before spending money on it.

The Interaction: What Type and How Serious?

There is no documented pharmacokinetic interaction between saw palmetto and metformin ER. They do not share metabolic pathways through CYP450 enzymes in any clinically meaningful way. Metformin is not metabolized by CYP enzymes at all; it is excreted unchanged by the kidneys. Saw palmetto is primarily metabolized by esterases. They do not compete for protein binding or affect each other's absorption.

The concerns are pharmacodynamic: they relate to what saw palmetto does in the body, independent of metformin.

Concern 1: Mild Antiplatelet Activity

Saw palmetto has demonstrated antiplatelet effects in laboratory and case-report evidence. A case series published in the Annals of Internal Medicine documented intraoperative bleeding in patients taking saw palmetto who had not disclosed it to their surgical team. The mechanism appears to involve inhibition of thromboxane A2 and cyclooxygenase pathways, though the clinical magnitude is substantially smaller than aspirin.

Metformin ER itself does not carry anticoagulant effects. For most women with PCOS taking metformin alone, saw palmetto's mild antiplatelet activity is unlikely to cause spontaneous bleeding. The concern rises if you are already taking NSAIDs regularly, fish oil at doses above 2 g/day, or any anticoagulant medication. Before any surgical procedure, including egg retrieval for IVF, you should stop saw palmetto at least two weeks in advance and tell your care team you were taking it.

Concern 2: Hormonal Effects on Insulin and Androgen Pathways

This is the more nuanced interaction for women with PCOS. Saw palmetto's 5-AR inhibition reduces DHT. Androgens, including DHT, have complex and partly opposing effects on insulin sensitivity depending on the tissue. Research published in Endocrinology showed that androgens can both impair and enhance insulin signaling in a dose- and tissue-dependent way. In women with PCOS, it is not fully established whether reducing DHT pharmacologically via 5-AR inhibition improves or worsens insulin resistance independent of testosterone changes.

In practical terms, this means saw palmetto and metformin may be working on overlapping androgen pathways, but there is no evidence they amplify each other's glucose-lowering effects to the point of causing hypoglycemia. Metformin does not cause hypoglycemia on its own. This is not a hypoglycemia risk.

What the Interaction Databases Say

The Natural Medicines database rates the saw palmetto plus metformin combination as having insufficient evidence to characterize a specific interaction. The FDA's MedWatch database does not contain a documented adverse event report linking the two specifically. The Mayo Clinic drug interaction checker lists no interaction between metformin and saw palmetto as of current records.

This is not the same as "proven safe." It means that specific interaction data has not been collected systematically, which is itself a consequence of the evidence gap in botanical-drug combination trials.

Who This Combination Is Right For (and Who Should Reconsider)

The following framework is designed to help you and your clinician decide whether adding saw palmetto to your metformin ER regimen makes sense at your life stage.

Reproductive Years (Not Actively Trying to Conceive)

If you are a woman in your 20s or 30s with PCOS, not currently trying to conceive, and using reliable contraception, this is the life stage where the combination is most defensible, assuming you have discussed it with your provider. Your androgen-related symptoms (hirsutism, acne, scalp hair loss) are the most likely reason you are considering saw palmetto, and metformin is already addressing your insulin resistance.

Reasonable candidates:

• Women with confirmed androgen excess on labs (elevated total or free testosterone, elevated DHEA-S)
• Women who cannot tolerate or access spironolactone
• Women who prefer to avoid hormonal contraceptives

Use caution or avoid if:

• You take any anticoagulant medication
• You have chronic liver disease (saw palmetto is metabolized hepatically and rare cases of hepatotoxicity have been reported; a 2011 case report in the Journal of General Internal Medicine documented cholestatic hepatitis attributed to saw palmetto)
• You take NSAIDs daily for conditions like endometriosis or pelvic pain

Trying to Conceive

Stop saw palmetto before attempting conception. Metformin ER may be continued through the first trimester under clinician guidance (see the pregnancy section below). Saw palmetto has no safety data in the preconception period and carries theoretical hormonal risks during early folliculogenesis. This is not a theorized concern to be weighed against benefits. There are no benefits established in the trying-to-conceive population that would justify the unknown risk.

Perimenopause

Women with PCOS entering perimenopause have a different hormonal profile than younger women. Testosterone and DHEA-S typically decline with age, but insulin resistance often worsens during the menopause transition as estrogen falls. A 2021 review in Menopause found that women with PCOS show a compressed hormonal transition but remain at elevated cardiometabolic risk throughout perimenopause.

In perimenopause, the androgen rationale for saw palmetto weakens as androgens are already declining. Metformin ER may have a more central role in managing glucose and lipid metabolism. Ask your clinician whether spironolactone or low-dose finasteride has a better evidence base for your specific symptoms at this stage.

Post-Menopause

Androgen-related symptoms in post-menopause that were attributed to PCOS may now reflect the normal androgen dominance that occurs when estrogen is absent. Saw palmetto data in postmenopausal women is essentially absent from the literature. Metformin has some evidence for cardiovascular risk reduction in this population through the UKPDS and follow-up data, but its role in post-menopausal PCOS is not formally addressed in current guidelines. This is an area where a specialist in PCOS and menopause is the appropriate resource.

Pregnancy and Lactation: Critical Rules

Metformin ER in Pregnancy

Metformin is FDA pregnancy category B, meaning animal studies have not shown harm and available human data has not confirmed teratogenicity. It crosses the placenta. The MiG trial (New England Journal of Medicine, 2008) randomized 751 pregnant women with gestational diabetes to metformin or insulin and found no increase in perinatal complications with metformin. For PCOS specifically, a 2014 Cochrane review found no significant increase in birth defects with first-trimester metformin exposure.

Many reproductive endocrinologists continue metformin through the first trimester in women with PCOS who have a history of early pregnancy loss, given evidence it may reduce miscarriage rates in insulin-resistant women. The decision to continue into the second and third trimesters should be made with your OB-GYN or MFM specialist.

Saw Palmetto in Pregnancy: Contraindicated

Saw palmetto is CONTRAINDICATED in pregnancy. It has known hormonal activity, including 5-AR inhibition and potential estrogenic and antiestrogenic effects documented in vitro. The Natural Medicines Comprehensive Database classifies saw palmetto as "likely unsafe" in pregnancy based on its hormonal mechanism. There are no human trials and no animal studies establishing a safe exposure level during gestation. Disruption of 5-AR activity during fetal development is directly linked to abnormal sexual differentiation in male fetuses; the risk to female fetal development is unknown but cannot be dismissed.

If you discover you are pregnant while taking saw palmetto, stop it immediately and inform your OB-GYN at your first prenatal appointment.

Lactation

No data exist on saw palmetto transfer into breast milk. The LactMed database (NIH) lists saw palmetto as having insufficient data to assess safety during breastfeeding. Given its hormonal activity and the absence of any safety signal in this population, avoid saw palmetto while breastfeeding. Metformin ER does transfer into breast milk, but at low levels; a 2005 study in Diabetes Care found infant exposure was approximately 0.28% of the maternal weight-adjusted dose, which most guidelines consider compatible with breastfeeding under clinician supervision.

Contraception Requirement

Saw palmetto is a hormonal active supplement. If you are taking it for PCOS symptom management and are sexually active without desire for pregnancy, use reliable contraception. This is the same standard applied to spironolactone (which requires contraception due to feminization risk in a male fetus). Saw palmetto's 5-AR inhibitory mechanism raises a parallel concern for fetal exposure even though it has not been formally categorized as a teratogen in the same legal sense.

How to Take Both If Your Clinician Agrees

If you and your provider decide the combination is appropriate, these practical points matter.

Dose and Timing

Metformin ER is typically taken once daily with the evening meal. Standard saw palmetto doses used in trials of male BPH range from 160 mg twice daily of a liposterolic extract (standardized to 85-95% fatty acids) to 320 mg once daily. No PCOS-specific dosing trial exists. Taking them at different times of day is not required for a pharmacokinetic reason, but separating them by several hours does no harm and is a reasonable default given the absence of interaction data.

What to Monitor

• Liver enzymes (ALT, AST) at baseline before starting saw palmetto, and at 3 months if you have any history of liver disease or alcohol use
• CBC if you are combining saw palmetto with any other antiplatelet or anticoagulant agent
• Fasting glucose and insulin at 3-month intervals to confirm metformin ER is working; saw palmetto will not confound these readings
• Androgen panel (total testosterone, free testosterone, DHEA-S, SHBG) at 6 months to assess whether your androgen excess is responding. This also gives your clinician objective data to decide whether saw palmetto is adding anything beyond what metformin is already accomplishing

When to Stop Saw Palmetto Immediately

Stop saw palmetto and contact your provider if you experience:

• Unusual bruising or bleeding that is not explained by your menstrual cycle
• Jaundice, right upper quadrant pain, or dark urine (signs of hepatotoxicity)
• A positive pregnancy test
• Any scheduled surgery or invasive procedure within two weeks

The Evidence Gap You Deserve to Know About

WomanRx editorial board reviewer Dr. Priya Sharma, MD, notes: "The fundamental problem with advising women on saw palmetto for PCOS is that virtually every mechanism study and every clinical trial was conducted in men with prostate disease. We are extrapolating across sex, age, and condition simultaneously. Women with PCOS deserve trials designed for them, and until those exist, the honest answer is that we do not know whether saw palmetto's androgen-reducing effects translate into meaningful symptom relief in PCOS, or whether the safety profile in reproductive-age women differs from what we see in older men."

This is not a reason to never use saw palmetto. Women make reasonable decisions about supplements with incomplete evidence every day. It is a reason to treat it as a pharmacologically active substance rather than a harmless tea, and to tell your prescriber you are taking it.

The PCOS supplement literature is improving. A 2023 review in Nutrients examined multiple supplements studied alongside metformin in PCOS, including inositol, berberine, N-acetylcysteine, and zinc, and found inositol had the strongest female-specific evidence base for ovulation and androgen reduction. Saw palmetto was not included because no qualifying trials in women existed. That absence is its own data point.

Talking to Your Provider: What to Actually Say

Many women hesitate to mention supplements to their prescribers. Say this directly: "I am taking saw palmetto for my PCOS symptoms, specifically for hirsutism and hair loss. I want to make sure it does not interfere with my metformin ER or anything else you might prescribe."

Your provider should:

1. Note it in your medication list (supplements belong there)
2. Check for bleeding risk if you take any other medications
3. Order a baseline liver panel if you have not had one recently
4. Revisit the decision in 6 months with androgen labs in hand

If your provider dismisses the question without engaging, that is a gap in care. Supplement-drug interactions in PCOS are a legitimate clinical topic and your provider should treat them as such.